Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Everest Medicines Announces Up to HK$100 million Additional Share Repurchase Program 2021-11-08 08:15
Everest Medicines Announces Up to HK$100 million Additional Share Repurchase Program 2021-11-08 08:10
Innovent Publishes the Preclinical Results of IBI319 (Anti PD-1/CD137 Bispecific Antibody) in Nature Communications 2021-11-08 08:00
Wegovy™ Demonstrated Significant and Sustained Weight Loss in Two-Year Study in Adults With Obesity 2021-11-05 20:58
PromarkerD significantly outperforms current standard of care tests in predicting future kidney function decline 2021-11-05 20:37
New Data at ASH 2021 Reinforces the Strength of Servier's Hematology Portfolio 2021-11-05 08:05
EpiVax licenses Tregitope Technology to Maruho Co., Ltd. for development of Tregitope-based Therapies to Treat Autoimmune Condition 2021-11-04 21:27
Gracell Biotechnologies to Present Preclinical Results of TruUCAR-enabled CD19/CD7 Dual-Directed Allogeneic CAR-T Cell Therapy (GC502) for B-Cell Malignancies at the 63rd ASH Annual Meeting 2021-11-04 21:05
I-Mab to Present Clinical Data of Lemzoparlimab in Combination with Rituximab in Non-Hodgkins's Lymphoma at ASH 2021 2021-11-04 21:00
Taizhou, China: Building a Famous Chinese Medical City with Efforts 2021-11-04 20:16
Tetracore, Inc. Introduces First USDA-Licensed Real-Time PCR Test for the Detection of African Swine Fever Virus in Swine Whole Blood and Spleen Samples 2021-11-04 20:02
Alterity Therapeutics Announces New Publications Providing Further Evidence of the Potential of ATH434 to Treat Neurodegenerative Diseases 2021-11-04 19:30
Innovent Announces NMPA Acceptance of a Supplemental New Drug Application for Sintilimab in Combination with Chemotherapy as First-Line Treatment for Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma 2021-11-04 17:00
New progress of studies on Lianhua Qingwen's mechanism to fight against SARS-CoV-2 2021-11-04 12:56
Novavax Files COVID-19 Vaccine for Provisional Approval in New Zealand 2021-11-03 22:14
Gold Technology for Immune Response Cancer Therapy Licensed to OncoTEX 2021-11-03 22:00
ERT and Bioclinica become Clario, The Leading Technology Solutions Company for Clinical Trial Innovation and Evidence 2021-11-03 21:33
Standigm Files PCT Patent Application of AI-driven Repurposed Drugs for Primary Mitochondrial Disease 2021-11-03 21:00
Vazyme to Reveal Its Latest COVID-19 Testing Products and Solutions at MEDICA 2021 2021-11-03 15:00
Vazyme to Reveal Its Latest COVID-19 Testing Products and Solutions at MEDICA 2021 2021-11-03 15:00
1 200 201 202 203 204 440